Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.
In a groundbreaking development for HIV prevention, the efficacy and safety of a six-monthly injection containing the antiretroviral drug lenacapavir have been confirmed through two pivotal studies.
From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...
The Biden administration on Oct. 21 issued a new proposed rule that would require health insurance providers to cover an ...
Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...
Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...
Health NGO, Right to Care, highlights the urgent need for circumcision among boys aged 15 and older in KwaZulu-Natal to ...
Doctors and front-line workers are watching closely as HIV rates increase significantly in Alberta.An annual Alberta Health ...
South Africa: KZN Makes Significant Strides in HIV but Males 15 and Older in KZN Urged to Circumcise
While the recent study by the Human Sciences Research Council (HSRC) revealed that people living with HIV in KwaZulu-Natal ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
LGBTQ Nation on MSN1d
Biden administration adds injectable PrEP requirement for insurance providersThe Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback